Source:http://linkedlifedata.com/resource/pubmed/id/18309354
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
2008-4-9
|
pubmed:abstractText |
Anti-tumor-associated glycoprotein (TAG)-72 PEG-immunoliposomes (PILs) were prepared by conjugation of Fab' fragments of recombinant humanized monoclonal antibody, HuCC49, to sterically stabilize unilamellar liposomes (90-110 nm in diameter) to target TAG-72-overexpressing cancer cells. The liposomes consisted of 1-palmitonyl-2-oleoyl-sn-glycerol-3-phosphocholine (POPC), 92 mol percent, O,O'-dymyrisyl-N-lysyl aspartate (DMKD cationic lipid), 4 mol percent, distearoyl-phosphatidyl-ethanolamine-polyethylene glycol 2000 (DSPE-PEG(2000)), 3 mol percent and DSPE-maleimide (DSPE-PEG(2000)-Mal), 1 mol percent. These anti-TAG-72 PILs were able to adhere to the surface of TAG-72-overexpressing LS174 T human colon cancer cells more effectively than conventional liposomes. Also, in vitro gene transfection of the LS174 T cells by the anti-TAG-72 PILs in the presence of a high concentration of fetal bovine serum (up to 60%) was greater than that by conventional cationic lipoplexes. Intravenously administered anti-TAG-72 PILs efficiently localized in the LS174 T tumor tissues, while the non-targeted conventional liposomes did not. Intravenous administration of the anti-TAG-72 PILs containing plasmids encoding antiangiogenic proteins, such as angiostatin K1/3, endostatin and saxatilin, significantly inhibited in vivo growth of LS174 T tumors and angiogenesis in the tumor tissues. These results demonstrated the potential of TAG-72-mediated targeting of immunoliposomes as a modality for systemic gene delivery to human colon cancer cells.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal,
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, Neoplasm,
http://linkedlifedata.com/resource/pubmed/chemical/Glycoproteins,
http://linkedlifedata.com/resource/pubmed/chemical/Immunoglobulin Fab Fragments,
http://linkedlifedata.com/resource/pubmed/chemical/Liposomes,
http://linkedlifedata.com/resource/pubmed/chemical/tumor-associated antigen 72
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
1476-5500
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
15
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
331-40
|
pubmed:meshHeading |
pubmed-meshheading:18309354-Animals,
pubmed-meshheading:18309354-Antibodies, Monoclonal,
pubmed-meshheading:18309354-Antigens, Neoplasm,
pubmed-meshheading:18309354-CHO Cells,
pubmed-meshheading:18309354-Cell Line, Tumor,
pubmed-meshheading:18309354-Colonic Neoplasms,
pubmed-meshheading:18309354-Cricetinae,
pubmed-meshheading:18309354-Cricetulus,
pubmed-meshheading:18309354-Gene Therapy,
pubmed-meshheading:18309354-Glycoproteins,
pubmed-meshheading:18309354-Humans,
pubmed-meshheading:18309354-Immunoglobulin Fab Fragments,
pubmed-meshheading:18309354-Liposomes,
pubmed-meshheading:18309354-Plasmids
|
pubmed:year |
2008
|
pubmed:articleTitle |
Targeted gene therapy of LS174 T human colon carcinoma by anti-TAG-72 immunoliposomes.
|
pubmed:affiliation |
Department of Biomedical Laboratory Science, Institute of Health Science, Yonsei University, Wonju, Republic of Korea.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|